These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 5970414)

  • 1. [Effects of iodine on the blood coagulation, anticoagulation and fibrinolytic systems in patients with atherosclerosis].
    Shershevskiĭ MG; Rassokhin VM
    Kardiologiia; 1966; 6(1):74-7. PubMed ID: 5970414
    [No Abstract]   [Full Text] [Related]  

  • 2. Fibrinolytic effects of defibrotide in atherosclerotic patients.
    Patrassi GM; Sartori MT; Viero ML; Scapinello MP; Boeri G; Girolami A
    Semin Thromb Hemost; 1991; 17 Suppl 1():101-5. PubMed ID: 2068562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Modifications of fibrinolysis and coagulation activity in arteriosclerotic patients treated with a polysulfoester of pentosan (SP-54). I].
    Cajozzo A; Citarrella P; Malleo C
    Boll Soc Ital Cardiol; 1971; 16(3):117-26. PubMed ID: 4110180
    [No Abstract]   [Full Text] [Related]  

  • 4. [Blood coagulation characteristics and fibrinolytic activity in patients with coronary arteriosclerosis during a course of treatment with vetrazine].
    Agapova EN; Krutovskaia OV; Mikhaĭlovskaia IG
    Kardiologiia; 1968 Dec; 8(12):130-2. PubMed ID: 5736735
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the mechanism of action of iodide compounds in atherosclerosis].
    Kaznacheev VP; Dzizinskiĭ AA; Chumakova VP; Shchepin VA
    Kardiologiia; 1966; 6(6):67-70. PubMed ID: 6001687
    [No Abstract]   [Full Text] [Related]  

  • 6. [Shifts in coagulating and fibrinolytic activity of the blood following the administration of nerobol in patients with coronary atherosclerosis].
    Kratovskaia OV; Zalaldinova NB; Afaunova VI; Denisova TP; Lebedeva SN
    Ter Arkh; 1972 Sep; 44(9):29-31. PubMed ID: 4660396
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antilipemic and fibrinolytic activity of an extractive mucopolysaccharide in atherosclerotic disease].
    Isidori A; Butti A; Rossi G
    Minerva Med; 1969 Dec; 60(99 Suppl):5077-81. PubMed ID: 4188592
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of glutathione on the development of atherosclerosis and on blood coagulation].
    Ol'shanskiĭ ChS; Khanin AL
    Patol Fiziol Eksp Ter; 1974; (1):82-5. PubMed ID: 4459793
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of the saluretic etozoline on the blood coagulation and fibrinolytic systems and other clinical parameters in healthy individuals].
    Goossens N; Marshall M
    Med Welt; 1978 Jun; 29(26):1091-5. PubMed ID: 672573
    [No Abstract]   [Full Text] [Related]  

  • 10. Study of serum lipid fractions as related to blood coagulation, fibrinolysis and platelet aggregation in cholesterol fed rabbits and in arteriosclerotic patients given clofibrate.
    Baldoni E; Egge H; Cuttin S; Murawski U; Gibelli A; Giarola P
    Farmaco Sci; 1973 Sep; 28(9):713-21. PubMed ID: 4749857
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrinolysis and coagulation. Effect of calcium and of coagulation on the lysis of fibrin clots.
    Helle I
    Scand J Haematol Suppl; 1968; 4():1-46. PubMed ID: 4181525
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of an adrenaline-heparin complex on blood lipolytic activity in animals during normal and depressed states of the anticoagulation system].
    Bazaz'ian GG; Liapina LA; Mendelevich OA
    Vopr Med Khim; 1974; 20(5):476-82. PubMed ID: 4456797
    [No Abstract]   [Full Text] [Related]  

  • 13. [Blood coagulation and fibrinolytic activity of the erythrocytes in patients with stage II-III hypertension subjected to combined treatment].
    Gritsiuk AI; Abdel-Kerim AI
    Ter Arkh; 1983; 55(9):59-68. PubMed ID: 6635982
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies of coagulation and fibrinolysis of the arterial and venous blood in normal subjects and patients with atherosclerosis.
    NAIMI S; GOLDSTEIN R; PROGER S
    Circulation; 1963 May; 27():904-18. PubMed ID: 13937272
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pharmacological aspects of fibrinolysis].
    Prino G; Mantovani M
    Boll Chim Farm; 1969 Dec; 108(12):727-60 passimf. PubMed ID: 4911753
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood coagulating and fibrinolytic properties of human eye tissues].
    Romashchenko AD; Balabanov VI; Skipetkov VP
    Vestn Oftalmol; 1977; (2):35-7. PubMed ID: 860363
    [No Abstract]   [Full Text] [Related]  

  • 17. Changes in spontaneous fibrinolytic activity during use of oral contraceptives.
    Hedlin AM; Monkhouse FC
    Obstet Gynecol; 1971 Feb; 37(2):225-32. PubMed ID: 5539358
    [No Abstract]   [Full Text] [Related]  

  • 18. [The effect of riboflavin on the blood coagulation and anticoagulation systems in patients with atherosclerosis and hypertension].
    Borets VM
    Klin Med (Mosk); 1968 Aug; 46(8):37-42. PubMed ID: 5707099
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical evaluation of a fribrinolytic drug in an experimental cross-over study].
    Bizzi B; Butti A
    Minerva Med; 1969 Dec; 60(99 Suppl):5062-7. PubMed ID: 4188590
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of hypotiazide and aldactone on the blood coagulation and anticoagulation systems].
    Gaianova MN
    Kardiologiia; 1973 May; 13(5):114-7. PubMed ID: 4720553
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.